SCHEMBL25820810

SCHEMBL25820810

O=C(c1cccc(Nc2ccncc2)c1)N1CCc2ccc(Oc3ccccc3)cc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.43
ALDH1A1 P00352 2/20 0.43
HPGD P15428 1/20 0.43
STAT3 P40763 1/20 0.43
GAA P10253 1/20 0.43
HTT P42858 1/20 0.43
CYP11B1 P15538 1/20 0.42
CYP11B2 P19099 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
TSHR P16473 1/20 0.41
XIAP P98170 1/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
RAB9A P51151 2/20 0.41
MAPT P10636 1/20 0.41
CFTR P13569 1/20 0.41
HTR2A P28223 1/20 0.40
HTR2C P28335 1/20 0.40
LMNA P02545 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24010367 0.96 STAT3 (0.42) FAAHALDH1A1HPGDSTAT3GAA
SCHEMBL25820812 0.89 MEN1 (0.43) FAAHALDH1A1HPGDGAAHTT
SCHEMBL24010366 0.88 CYP11B2 (0.40) ALDH1A1STAT3GAAHTTCYP11B1
SCHEMBL25820804 0.83 UCHL1 (0.45) FAAHALDH1A1HPGDSTAT3GAA
SCHEMBL25827157 0.79 HTR2C (0.40) STAT3GAAHTTCYP11B1CYP11B2
SCHEMBL25820814 0.79 RAB9A (0.40) ALDH1A1HPGDSMN1; SMN2TSHRMEN1
SCHEMBL24010133 0.79 STAT3 (0.44) ALDH1A1HPGDSTAT3GAAHTT
SCHEMBL24010376 0.77 LMNA (0.40) ALDH1A1CYP11B1CYP11B2SMN1; SMN2MEN1
SCHEMBL25822237 0.76 LMNA (0.45) ALDH1A1HPGDRAB9AMAPTHTR2C
SCHEMBL24010132 0.75 DNMT1 (0.44) ALDH1A1GAAHTTXIAPKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219927-A1 AKT3 MODULATORS Georgiamune Inc. 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219927-A1 AKT3 MODULATORS AKT3, AKT2, PIK3CA FAAH 4405/4885ALDH1A1 3871/4885HPGD 2768/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.